{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:28:59Z","timestamp":1791134939003,"version":"4.1.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Parkinson's disease (PD) is the second most common neurodegenerative disorder. One of the most widely used techniques to diagnose PD is a Single Photon Emission Computer Tomography (SPECT) scan to visualise the integrity of the dopaminergic pathways in the brain. Despite this there remains some discussion on the value of SPECT in the differential diagnosis of PD. We did a meta-analysis of all the existing literature on the diagnostic accuracy of both pre- and post-synaptic SPECT imaging in the differential diagnosis of PD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Relevant studies were searched in Medline, EMBASE and Cochrane databases with back-searching of their reference lists. We limited our analysis to studies with a clinically relevant methodology: i.e. when they assessed the ability of the SPECT to provide 1. diagnosis of PD in an early phase vs. normalcy; 2 diagnostic differentiation between PD and essential tremor (ET); 3. distinguishing between PD and vascular parkinsonism (VP); 4. delineation of PD from atypical parkinsonian syndromes (APS). Gold standard was, dependent on the study type, clinical examination at initial visit or follow-up, and\/or response to dopaminergic agents.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The search gave 185 hits, of which we deemed 32 suitable for our analysis. From these we recalculated the diagnostic odds ratio of SPECT for the clinical questions above. The pooled odds ratio (with 95%CI) for presynaptic SPECT scan's ability to distinguish between early PD and normalcy was 60 (13 \u2013 277). For the ability to differentiate between PD and ET this ratio was 210 (79\u2013562). The ratio for presynaptic SPECT's ability to delineate PD from VP was 105 (32 \u2013 348). The mean odds ratio for the presynaptic SPECT scans to differentiate between PD and the two APS was 2 (1 \u2013 4), and for the postsynaptic SPECT imaging this was 19 (9\u201336).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>SPECT with presynaptic radiotracers is relatively accurate to differentiate patients with PD in an early phase from normalcy, patients with PD from those with ET, and PD from VP.<\/jats:p>\n            <jats:p>The accuracy of SPECT with both presynaptic and postsynaptic tracers to differentiate between PD and APS is relatively low.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2377-7-27","type":"journal-article","created":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T18:13:24Z","timestamp":1188670404000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes"],"prefix":"10.1186","volume":"7","author":[{"given":"Annemarie MM","family":"Vlaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinus JPG","family":"van Kroonenburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfons GH","family":"Kessels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim EJ","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,9,1]]},"reference":[{"key":"27_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0895-4356(01)00425-5","volume":"55","author":"A Elbaz","year":"2002","unstructured":"Elbaz A, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA: Risk tables for parkinsonism and Parkinson's disease. J Clin Epidemiol. 2002, 55: 25-31. 10.1016\/S0895-4356(01)00425-5.","journal-title":"J Clin Epidemiol"},{"key":"27_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992, 55: 181-184.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"27_CR3","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1212\/WNL.49.1_Suppl_1.S10","volume":"49","author":"WC Koller","year":"1997","unstructured":"Koller WC, Montgomery EB: Issues in the early diagnosis of Parkinson's disease. Neurology. 1997, 49: S10-25.","journal-title":"Neurology"},{"key":"27_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1001\/archneur.1993.00540020018011","volume":"50","author":"AJ Hughes","year":"1993","unstructured":"Hughes AJ, Daniel SE, Blankson S, Lees AJ: A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol. 1993, 50: 140-148.","journal-title":"Arch Neurol"},{"key":"27_CR5","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1212\/WNL.57.8.1497","volume":"57","author":"AJ Hughes","year":"2001","unstructured":"Hughes AJ, Daniel SE, Lees AJ: Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology. 2001, 57: 1497-1499.","journal-title":"Neurology"},{"key":"27_CR6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1017\/S0317167100031814","volume":"18","author":"AH Rajput","year":"1991","unstructured":"Rajput AH, Rozdilsky B, Rajput A: Accuracy of clinical diagnosis in parkinsonism--a prospective study. Can J Neurol Sci. 1991, 18: 275-278.","journal-title":"Can J Neurol Sci"},{"key":"27_CR7","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/brain\/awf117","volume":"125","author":"H Watanabe","year":"2002","unstructured":"Watanabe H, Saito Y, Terao S, Ando T, Kachi T, Mukai E, Aiba I, Abe Y, Tamakoshi A, Doyu M, Hirayama M, Sobue G: Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain. 2002, 125: 1070-1083. 10.1093\/brain\/awf117.","journal-title":"Brain"},{"key":"27_CR8","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/archneur.55.7.969","volume":"55","author":"I Litvan","year":"1998","unstructured":"Litvan I, MacIntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, Bartko JJ, Jankovic J, McKee A, Brandel JP, Chaudhuri KR, Lai EC, D'Olhaberriague L, Pearce RK, Agid Y: Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol. 1998, 55: 969-978. 10.1001\/archneur.55.7.969.","journal-title":"Arch Neurol"},{"key":"27_CR9","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S1474-4422(04)00736-7","volume":"3","author":"P Piccini","year":"2004","unstructured":"Piccini P, Whone A: Functional brain imaging in the differential diagnosis of Parkinson's disease. Lancet Neurol. 2004, 3: 284-290. 10.1016\/S1474-4422(04)00736-7.","journal-title":"Lancet Neurol"},{"key":"27_CR10","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S1474-4422(04)00823-3","volume":"3","author":"CE Clarke","year":"2004","unstructured":"Clarke CE: Neuroprotection and pharmacotherapy for motor symptoms in Parkinson's disease. Lancet Neurol. 2004, 3: 466-474. 10.1016\/S1474-4422(04)00823-3.","journal-title":"Lancet Neurol"},{"key":"27_CR11","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00415-004-0549-2","volume":"251","author":"K Dujardin","year":"2004","unstructured":"Dujardin K, Defebvre L, Duhamel A, Lecouffe P, Rogelet P, Steinling M, Destee A: Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patients. J Neurol. 2004, 251: 1383-1392. 10.1007\/s00415-004-0549-2.","journal-title":"J Neurol"},{"key":"27_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/ana.20160","volume":"56","author":"MM Ponsen","year":"2004","unstructured":"Ponsen MM, Stoffers D, Booij J, van Eck-Smit BLF, Wolters EC, Berendse HW: Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol. 2004, 56: 173-181. 10.1002\/ana.20160.","journal-title":"Ann Neurol"},{"key":"27_CR13","first-page":"VI\/33","volume":"251 Suppl 6","author":"A Storch","year":"2004","unstructured":"Storch A, Hofer A, Kruger R, Schulz JB, Winkler J, Gerlach M: New developments in diagnosis and treatment of Parkinson's disease--from basic science to clinical applications. J Neurol. 2004, 251 Suppl 6: VI\/33-8.","journal-title":"J Neurol"},{"key":"27_CR14","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/mds.20232","volume":"19","author":"U Walter","year":"2004","unstructured":"Walter U, Klein C, Hilker R, Benecke R, Pramstaller PP, Dressler D: Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord. 2004, 19: 1445-1449. 10.1002\/mds.20232.","journal-title":"Mov Disord"},{"key":"27_CR15","first-page":"1339","volume":"7","author":"HH Fernandez","year":"2001","unstructured":"Fernandez HH, Friedman JH, Fischman AJ, Noto RB, Lannon MC: Is altropane SPECT more sensitive to fluoroDOPA PET for detecting early Parkinson's disease?. Med Sci Monit. 2001, 7: 1339-1343.","journal-title":"Med Sci Monit"},{"key":"27_CR16","first-page":"999","volume":"44","author":"WS Huang","year":"2003","unstructured":"Huang WS, Chiang YH, Lin JC, Chou YH, Cheng CY, Liu RS: Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients. J Nucl Med. 2003, 44: 999-1005.","journal-title":"J Nucl Med"},{"key":"27_CR17","first-page":"1760","volume":"37","author":"T Ishikawa","year":"1996","unstructured":"Ishikawa T, Dhawan V, Kazumata K, Chaly T, Mandel F, Neumeyer J, Margouleff C, Babchyck B, Zanzi I, Eidelberg D: Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP\/SPECT and fluorine-18-FDOPA\/PET. J Nucl Med. 1996, 37: 1760-1765.","journal-title":"J Nucl Med"},{"key":"27_CR18","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/00006231-199410000-00006","volume":"15","author":"J Schwarz","year":"1994","unstructured":"Schwarz J, Antonini A, Tatsch K, Kirsch CM, Oertel WH, Leenders KL: Comparison of 123I-IBZM SPECT and 11C-raclopride PET findings in patients with parkinsonism. Nucl Med Commun. 1994, 15: 806-813. 10.1097\/00006231-199410000-00006.","journal-title":"Nucl Med Commun"},{"key":"27_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s002590050374","volume":"26","author":"J Booij","year":"1999","unstructured":"Booij J, Tissingh G, Winogrodzka A, van Royen EA: Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism. Eur J Nucl Med. 1999, 26: 171-182. 10.1007\/s002590050374.","journal-title":"Eur J Nucl Med"},{"key":"27_CR20","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/archneur.57.3.369","volume":"57","author":"J Jankovic","year":"2000","unstructured":"Jankovic J, Rajput AH, McDermott MP, Perl DP: The evolution of diagnosis in early Parkinson disease. Parkinson Study Group. Arch Neurol. 2000, 57: 369-372. 10.1001\/archneur.57.3.369.","journal-title":"Arch Neurol"},{"key":"27_CR21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/jnnp.73.2.134","volume":"73","author":"Z Walker","year":"2002","unstructured":"Walker Z, Costa DC, Walker RW, Shaw K, Gacinovic S, Stevens T, Livingston G, Ince P, McKeith IG, Katona CL: Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry. 2002, 73: 134-140. 10.1136\/jnnp.73.2.134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"27_CR22","first-page":"2281","volume":"146","author":"WL Deville","year":"2002","unstructured":"Deville WL, Bossuyt PM, de Vet HC, Bezemer PD, Bouter LM, Assendelft WJ: Systematic reviews in practice. X. Searching, selecting and the methodological assessment of diagnostic evaluation research. Ned Tijdschr Geneeskd. 2002, 146: 2281-2284.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"27_CR23","first-page":"656","volume":"143","author":"WJ Assendelft","year":"1999","unstructured":"Assendelft WJ, van Tulder MW, Scholten RJ, Bouter LM: [The practice of systematic reviews. II. Searching and selection of studies]. Ned Tijdschr Geneeskd. 1999, 143: 656-661.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"27_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2288-2-9","volume":"2","author":"WL Deville","year":"2002","unstructured":"Deville WL, Buntinx F, Bouter LM, Montori VM, de Vet HC, van der Windt DA, Bezemer PD: Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol. 2002, 2: 9-10.1186\/1471-2288-2-9.","journal-title":"BMC Med Res Methodol"},{"key":"27_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2288-6-9","volume":"6","author":"PF Whiting","year":"2006","unstructured":"Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J: Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol. 2006, 6: 9-10.1186\/1471-2288-6-9.","journal-title":"BMC Med Res Methodol"},{"key":"27_CR26","first-page":"271","volume-title":"BMJ Publishing Group, London","author":"M Egger","year":"2005","unstructured":"Egger M, Smith GD, Altman DG: Systematic reviews in health care. BMJ Publishing Group, London. 2005, 271-"},{"key":"27_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ. 2003, 327: 557-560. 10.1136\/bmj.327.7414.557.","journal-title":"BMJ"},{"issue":"Suppl 16","key":"27_CR28","first-page":"233","volume":"22","author":"AMM Vlaar","year":"2007","unstructured":"Vlaar AMM, Kessels AGH, Nijs de T, Winogrodzka A, Mess WH, Kroonenburgh MJPG, Weber WEJ: Additional value of SPECT imaging in comparance with clinical diagnosis in 248 patients with parkinsonism. Movement Disorders. 2007, 22 (Suppl 16): 233-","journal-title":"Movement Disorders"},{"key":"27_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-3-7091-6842-4_2","volume":"50","author":"T Brucke","year":"1997","unstructured":"Brucke T, Asenbaum S, Pirker W, Djamshidian S, Wenger S, Wober C, Muller C, Podreka I: Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. J Neural Transm Suppl. 1997, 50: 9-24.","journal-title":"J Neural Transm Suppl"},{"key":"27_CR30","first-page":"49","volume":"45","author":"CS Lu","year":"2004","unstructured":"Lu CS, Weng YH, Chen MC, Chen RS, Tzen KY, Wey SP, Ting G, Chang HC, Yen TC: 99mTc-TRODAT-1 imaging of multiple system atrophy. J Nucl Med. 2004, 45: 49-55.","journal-title":"J Nucl Med"},{"key":"27_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/00006231-200501000-00007","volume":"26","author":"G Popperl","year":"2005","unstructured":"Popperl G, Radau P, Linke R, Hahn K, Tatsch K: Diagnostic performance of a 3-D automated quantification method of dopamine D2 receptor SPECT studies in the differential diagnosis of parkinsonism. Nucl Med Commun. 2005, 26: 39-43. 10.1097\/00006231-200501000-00007.","journal-title":"Nucl Med Commun"},{"key":"27_CR32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s00259-004-1667-x","volume":"32","author":"RL Swanson","year":"2005","unstructured":"Swanson RL, Newberg AB, Acton PD, Siderowf A, Wintering N, Alavi A, Mozley PD, Plossl K, Udeshi M, Hurtig H: Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease. Eur J Nucl Med Mol Imaging. 2005, 32: 302-307. 10.1007\/s00259-004-1667-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"27_CR33","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s007020050124","volume":"105","author":"S Asenbaum","year":"1998","unstructured":"Asenbaum S, Pirker W, Angelberger P, Bencsits G, Pruckmayer M, Brucke T: [123I]beta-CIT and SPECT in essential tremor and Parkinson's disease. J Neural Transm. 1998, 105: 1213-1228. 10.1007\/s007020050124.","journal-title":"J Neural Transm"},{"key":"27_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/mds.870130107","volume":"13","author":"J Schwarz","year":"1998","unstructured":"Schwarz J, Tatsch K, Gasser T, Arnold G, Pogarell O, Kunig G, Oertel WH: 123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism. Mov Disord. 1998, 13: 16-19. 10.1002\/mds.870130107.","journal-title":"Mov Disord"},{"key":"27_CR35","first-page":"S17","volume":"43","author":"J Schwarz","year":"1993","unstructured":"Schwarz J, Tatsch K, Arnold G, Ott M, Trenkwalder C, Kirsch CM, Oertel WH: 123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonism. Neurology. 1993, 43: S17-20.","journal-title":"Neurology"},{"key":"27_CR36","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s002590000460","volume":"28","author":"J Booij","year":"2001","unstructured":"Booij J, Speelman JD, Horstink MW, Wolters EC: The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med. 2001, 28: 266-272. 10.1007\/s002590000460.","journal-title":"Eur J Nucl Med"},{"key":"27_CR37","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/mds.870120610","volume":"12","author":"J Schwarz","year":"1997","unstructured":"Schwarz J, Tatsch K, Gasser T, Arnold G, Oertel WH: [123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy. Mov Disord. 1997, 12: 898-902. 10.1002\/mds.870120610.","journal-title":"Mov Disord"},{"key":"27_CR38","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00259-002-0938-7","volume":"29","author":"A Lokkegaard","year":"2002","unstructured":"Lokkegaard A, Werdelin LM, Friberg L: Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand. Eur J Nucl Med Mol Imaging. 2002, 29: 1623-1629. 10.1007\/s00259-002-0938-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"27_CR39","volume-title":"Eur J Nucl Med Mol Imaging","author":"D Stoffers","year":"2005","unstructured":"Stoffers D, Booij J, Bosscher L, Winogrodzka A, Wolters EC, Berendse HW: Early-stage [(123)I]beta-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson's disease. Eur J Nucl Med Mol Imaging. 2005"},{"key":"27_CR40","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/1531-8257(200101)16:1<124::AID-MDS1007>3.0.CO;2-R","volume":"16","author":"TH Haapaniemi","year":"2001","unstructured":"Haapaniemi TH, Ahonen A, Torniainen P, Sotaniemi KA, Myllyla VV: [123I]beta-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients. Mov Disord. 2001, 16: 124-130. 10.1002\/1531-8257(200101)16:1<124::AID-MDS1007>3.0.CO;2-R.","journal-title":"Mov Disord"},{"key":"27_CR41","first-page":"1303","volume":"42","author":"WS Huang","year":"2001","unstructured":"Huang WS, Lin SZ, Lin JC, Wey SP, Ting G, Liu RS: Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging. J Nucl Med. 2001, 42: 1303-1308.","journal-title":"J Nucl Med"},{"key":"27_CR42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1001\/archneur.57.2.205","volume":"57","author":"J Schwarz","year":"2000","unstructured":"Schwarz J, Linke R, Kerner M, Mozley PD, Trenkwalder C, Gasser T, Tatsch K: Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosis. Arch Neurol. 2000, 57: 205-208. 10.1001\/archneur.57.2.205.","journal-title":"Arch Neurol"},{"key":"27_CR43","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00259-004-1480-6","volume":"31","author":"K Van Laere","year":"2004","unstructured":"Van Laere K, De Ceuninck L, Dom R, Van den Eynden J, Vanbilloen H, Cleynhens J, Dupont P, Bormans G, Verbruggen A, Mortelmans L: Dopamine transporter SPECT using fast kinetic ligands: 123I-FP-beta-CIT versus 99mTc-TRODAT-1. Eur J Nucl Med Mol Imaging. 2004, 31: 1119-1127. 10.1007\/s00259-004-1480-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"27_CR44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000007896","volume":"39","author":"T Muller","year":"1998","unstructured":"Muller T, Farahati J, Kuhn W, Eising EG, Przuntek H, Reiners C, Coenen HH: [123I]beta-CIT SPECT visualizes dopamine transporter loss in de novo parkinsonian patients. Eur Neurol. 1998, 39: 44-48. 10.1159\/000007896.","journal-title":"Eur Neurol"},{"key":"27_CR45","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1212\/WNL.52.7.1422","volume":"52","author":"MS Lee","year":"1999","unstructured":"Lee MS, Kim YD, Im JH, Kim HJ, Rinne JO, Bhatia KP: 123I-IPT brain SPECT study in essential tremor and Parkinson's disease. Neurology. 1999, 52: 1422-1426.","journal-title":"Neurology"},{"key":"27_CR46","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00702-004-0208-x","volume":"112","author":"M Plotkin","year":"2005","unstructured":"Plotkin M, Amthauer H, Klaffke S, Kuhn A, Ludemann L, Arnold G, Wernecke KD, Kupsch A, Felix R, Venz S: Combined (123)I-FP-CIT and (123)I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. J Neural Transm. 2005, 112: 677-692. 10.1007\/s00702-004-0208-x.","journal-title":"J Neural Transm"},{"key":"27_CR47","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1136\/jnnp.2004.045237","volume":"76","author":"J Eerola","year":"2005","unstructured":"Eerola J, Tienari PJ, Kaakkola S, Nikkinen P, Launes J: How useful is [123I]beta-CIT SPECT in clinical practice?. J Neurol Neurosurg Psychiatry. 2005, 76: 1211-1216. 10.1136\/jnnp.2004.045237.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"27_CR48","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","volume":"15","author":"TS Benamer","year":"2000","unstructured":"Benamer TS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, Speelman JD, Horstink MH, Sips HJ, Dierckx RA, Versijpt J, Decoo D, Van Der Linden C, Hadley DM, Doder M, Lees AJ, Costa DC, Gacinovic S, Oertel WH, Pogarell O, Hoeffken H, Joseph K, Tatsch K, Schwarz J, Ries V: Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord. 2000, 15: 503-510. 10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V.","journal-title":"Mov Disord"},{"key":"27_CR49","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/mds.10092","volume":"17","author":"W Gerschlager","year":"2002","unstructured":"Gerschlager W, Bencsits G, Pirker W, Bloem BR, Asenbaum S, Prayer D, Zijlmans JC, Hoffmann M, Brucke T: [123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease. Mov Disord. 2002, 17: 518-523. 10.1002\/mds.10092.","journal-title":"Mov Disord"},{"key":"27_CR50","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/mds.10042","volume":"17","author":"YJ Kim","year":"2002","unstructured":"Kim YJ, Ichise M, Ballinger JR, Vines D, Erami SS, Tatschida T, Lang AE: Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. Mov Disord. 2002, 17: 303-312. 10.1002\/mds.10042.","journal-title":"Mov Disord"},{"key":"27_CR51","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s002590050295","volume":"25","author":"C Messa","year":"1998","unstructured":"Messa C, Volonte MA, Fazio F, Zito F, Carpinelli A, d'Amico A, Rizzo G, Moresco RM, Paulesu E, Franceschi M, Lucignani G: Differential distribution of striatal [123I]beta-CIT in Parkinson's disease and progressive supranuclear palsy, evaluated with single-photon emission tomography. Eur J Nucl Med. 1998, 25: 1270-1276. 10.1007\/s002590050295.","journal-title":"Eur J Nucl Med"},{"key":"27_CR52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.1265","volume":"17","author":"W Pirker","year":"2002","unstructured":"Pirker W, Djamshidian S, Asenbaum S, Gerschlager W, Tribl G, Hoffmann M, Brucke T: Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study. Mov Disord. 2002, 17: 45-53. 10.1002\/mds.1265.","journal-title":"Mov Disord"},{"key":"27_CR53","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1552-6569.2002.tb00139.x","volume":"12","author":"C Oyanagi","year":"2002","unstructured":"Oyanagi C, Katsumi Y, Hanakawa T, Hayashi T, Thuy DD, Hashikawa K, Nagahama Y, Fukuyama H, Shibasaki H: Comparison of striatal dopamine D2 receptors in Parkinson's disease and progressive supranuclear palsy patients using [123I] iodobenzofuran single-photon emission computed tomography. J Neuroimaging. 2002, 12: 316-324.","journal-title":"J Neuroimaging"},{"key":"27_CR54","first-page":"519","volume":"60","author":"WH Oertel","year":"1993","unstructured":"Oertel WH, Schwarz J, Tatsch K, Arnold G, Gasser T, Kirsch CM: IBZM-SPECT as predictor for dopamimetic responsiveness of patients with de novo parkinsonian syndrome. Adv Neurol. 1993, 60: 519-524.","journal-title":"Adv Neurol"},{"key":"27_CR55","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/00006231-199108000-00005","volume":"12","author":"K Tatsch","year":"1991","unstructured":"Tatsch K, Schwarz J, Oertel WH, Kirsch CM: SPECT imaging of dopamine D2 receptors with 123I-IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease. Nucl Med Commun. 1991, 12: 699-707. 10.1097\/00006231-199108000-00005.","journal-title":"Nucl Med Commun"},{"key":"27_CR56","first-page":"1196","volume":"36","author":"A Buck","year":"1995","unstructured":"Buck A, Westera G, Sutter M, Albani C, Kung HF, vonSchulthess GK: Iodine-123-IBF SPECT evaluation of extrapyramidal diseases. J Nucl Med. 1995, 36: 1196-1200.","journal-title":"J Nucl Med"},{"key":"27_CR57","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/mds.20229","volume":"19","author":"K Seppi","year":"2004","unstructured":"Seppi K, Schocke MF, Donnemiller E, Esterhammer R, Kremser C, Scherfler C, Diem A, Jaschke W, Wenning GK, Poewe W: Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease. Mov Disord. 2004, 19: 1438-1445. 10.1002\/mds.20229.","journal-title":"Mov Disord"},{"key":"27_CR58","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/mds.870080406","volume":"8","author":"L Schelosky","year":"1993","unstructured":"Schelosky L, Hierholzer J, Wissel J, Cordes M, Poewe W: Correlation of clinical response in apomorphine test with D2-receptor status as demonstrated by 123I IBZM-SPECT. Mov Disord. 1993, 8: 453-458. 10.1002\/mds.870080406.","journal-title":"Mov Disord"},{"key":"27_CR59","first-page":"1711","volume":"38","author":"W Pirker","year":"1997","unstructured":"Pirker W, Asenbaum S, Wenger S, Kornhuber J, Angelberger P, Deecke L, Podreka I, Brucke T: Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease. J Nucl Med. 1997, 38: 1711-1717.","journal-title":"J Nucl Med"},{"key":"27_CR60","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/archneur.1993.00540050063017","volume":"50","author":"E van Royen","year":"1993","unstructured":"van Royen E, Verhoeff NF, Speelman JD, Wolters EC, Kuiper MA, Janssen AG: Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography. Arch Neurol. 1993, 50: 513-516.","journal-title":"Arch Neurol"},{"key":"27_CR61","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/1531-8257(200011)15:6<1158::AID-MDS1015>3.0.CO;2-0","volume":"15","author":"W Pirker","year":"2000","unstructured":"Pirker W, Asenbaum S, Bencsits G, Prayer D, Gerschlager W, Deecke L, Brucke T: [123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Mov Disord. 2000, 15: 1158-1167. 10.1002\/1531-8257(200011)15:6<1158::AID-MDS1015>3.0.CO;2-0.","journal-title":"Mov Disord"},{"key":"27_CR62","first-page":"1500","volume":"39","author":"JP Seibyl","year":"1998","unstructured":"Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS, van Dyck CH, Innis RB: Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients. J Nucl Med. 1998, 39: 1500-1508.","journal-title":"J Nucl Med"},{"key":"27_CR63","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/BF01728311","volume":"24","author":"J Booij","year":"1997","unstructured":"Booij J, Tissingh G, Winogrodzka A, Boer GJ, Stoof JC, Wolters EC, van Royen EA: Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease. Eur J Nucl Med. 1997, 24: 68-71. 10.1007\/BF01728311.","journal-title":"Eur J Nucl Med"},{"key":"27_CR64","first-page":"954","volume":"39","author":"J Hierholzer","year":"1998","unstructured":"Hierholzer J, Cordes M, Venz S, Schelosky L, Harisch C, Richter W, Keske U, Hosten N, Maurer J, Poewe W, Felix R: Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes. J Nucl Med. 1998, 39: 954-960.","journal-title":"J Nucl Med"},{"key":"27_CR65","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1002\/mds.10531","volume":"18","author":"W Pirker","year":"2003","unstructured":"Pirker W, Holler I, Gerschlager W, Asenbaum S, Zettinig G, Brucke T: Measuring the rate of progression of Parkinson's disease over a 5-year period with beta-CIT SPECT. Mov Disord. 2003, 18: 1266-1272. 10.1002\/mds.10531.","journal-title":"Mov Disord"},{"key":"27_CR66","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/1098-2396(200102)39:2<101::AID-SYN1>3.0.CO;2-1","volume":"39","author":"J Booij","year":"2001","unstructured":"Booij J, Bergmans P, Winogrodzka A, Speelman JD, Wolters EC: Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease. Synapse. 2001, 39: 101-108. 10.1002\/1098-2396(200102)39:2<101::AID-SYN1>3.0.CO;2-1.","journal-title":"Synapse"},{"key":"27_CR67","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/00019442-200201000-00005","volume":"10","author":"CH van Dyck","year":"2002","unstructured":"van Dyck CH, Seibyl JP, Malison RT, Laruelle M, Zoghbi SS, Baldwin RM, Innis RB: Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. Am J Geriatr Psychiatry. 2002, 10: 36-43. 10.1176\/appi.ajgp.10.1.36.","journal-title":"Am J Geriatr Psychiatry"},{"key":"27_CR68","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/ana.10609","volume":"54","author":"AL Whone","year":"2003","unstructured":"Whone AL, Watts RL, Stoessl AJ, Davis M, Reske S, Nahmias C, Lang AE, Rascol O, Ribeiro MJ, Remy P, Poewe WH, Hauser RA, Brooks DJ: Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study. Ann Neurol. 2003, 54: 93-101. 10.1002\/ana.10609.","journal-title":"Ann Neurol"},{"key":"27_CR69","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/archneur.56.5.529","volume":"56","author":"S Fahn","year":"1999","unstructured":"Fahn S: Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs Later L-DOPA. Arch Neurol. 1999, 56: 529-535. 10.1001\/archneur.56.5.529.","journal-title":"Arch Neurol"},{"key":"27_CR70","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/mds.10482","volume":"18","author":"HT Benamer","year":"2003","unstructured":"Benamer HT, Oertel WH, Patterson J, Hadley DM, Pogarell O, Hoffken H, Gerstner A, Grosset DG: Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations. Mov Disord. 2003, 18: 977-984. 10.1002\/mds.10482.","journal-title":"Mov Disord"},{"key":"27_CR71","first-page":"1688","volume":"45","author":"M Lorberboym","year":"2004","unstructured":"Lorberboym M, Djaldetti R, Melamed E, Sadeh M, Lampl Y: 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism. J Nucl Med. 2004, 45: 1688-1693.","journal-title":"J Nucl Med"},{"key":"27_CR72","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s002340050716","volume":"41","author":"J Schwarz","year":"1999","unstructured":"Schwarz J, Kraft E, Vogl T, Arnold G, Tatsch K, Oertel WH: Relative quantification of signal on T2-weighted images in the basal ganglia: limited value in differential diagnosis of patients with parkinsonism. Neuroradiology. 1999, 41: 124-128. 10.1007\/s002340050716.","journal-title":"Neuroradiology"},{"key":"27_CR73","first-page":"467","volume":"69","author":"G Pizzolato","year":"1996","unstructured":"Pizzolato G, Cagnin A, Rossato A, Chierichetti F, Fabbri M, Dam M, Ferlin G, Battistin L: Striatal dopamine D2 receptor alterations and response to L-DOPA in Parkinson's disease. A [123I]IBZM SPET study. Adv Neurol. 1996, 69: 467-473.","journal-title":"Adv Neurol"},{"key":"27_CR74","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1212\/WNL.42.3.556","volume":"42","author":"J Schwarz","year":"1992","unstructured":"Schwarz J, Tatsch K, Arnold G, Gasser T, Trenkwalder C, Kirsch CM, Oertel WH: 123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism. Neurology. 1992, 42: 556-561.","journal-title":"Neurology"},{"key":"27_CR75","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1055\/s-2008-1032726","volume":"159","author":"J Hierholzer","year":"1993","unstructured":"Hierholzer J, Cordes M, Schelosky L, Sander B, Bock JC, David I, Horowski R, Poewe W: [The differential diagnosis of Parkinson diseases--123I-IBZM-SPECT vs. the apomorphine test]. Rofo. 1993, 159: 86-90.","journal-title":"Rofo"},{"key":"27_CR76","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1007\/s00259-004-1578-x","volume":"31","author":"GM Knudsen","year":"2004","unstructured":"Knudsen GM, Karlsborg M, Thomsen G, Krabbe K, Regeur L, Nygaard T, Videbaek C, Werdelin L: Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy. Eur J Nucl Med Mol Imaging. 2004, 31: 1631-1638. 10.1007\/s00259-004-1578-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"27_CR77","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1097\/00006231-200111000-00007","volume":"22","author":"C Prunier","year":"2001","unstructured":"Prunier C, Tranquart F, Cottier JP, Giraudeau B, Chalon S, Guilloteau D, De Toffol B, Chossat F, Autret A, Besnard JC, Baulieu JL: Quantitative analysis of striatal dopamine D2 receptors with 123 I-iodolisuride SPECT in degenerative extrapyramidal diseases. Nucl Med Commun. 2001, 22: 1207-1214. 10.1097\/00006231-200111000-00007.","journal-title":"Nucl Med Commun"},{"key":"27_CR78","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1136\/jnnp.57.9.1047","volume":"57","author":"JB Schulz","year":"1994","unstructured":"Schulz JB, Klockgether T, Petersen D, Jauch M, Muller-Schauenburg W, Spieker S, Voigt K, Dichgans J: Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry. 1994, 57: 1047-1056.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"27_CR79","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0038-1629754","volume":"33","author":"G Berding","year":"1994","unstructured":"Berding G, Gratz KF, Kolbe H, Meyer GJ, Dengler R, Knoop BO, Hundeshagen H: 123I-IBZM SPECT: reconstruction methodology and results in parkinsonism and dystonia. Nuklearmedizin. 1994, 33: 194-199.","journal-title":"Nuklearmedizin"},{"key":"27_CR80","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-0038-1629787","volume":"36","author":"S Bettin","year":"1997","unstructured":"Bettin S, Kampfer I, Seese A, Schafer A, Reuter M, Lossner J, Dietrich J, Wagner A, Knapp WH: [Striatal uptake of I-123-beta-CIT and I-123-IBZM in patients with extrapyramidal symptoms]. Nuklearmedizin. 1997, 36: 167-172.","journal-title":"Nuklearmedizin"},{"key":"27_CR81","volume-title":"Brain","author":"C Scherfler","year":"2005","unstructured":"Scherfler C, Seppi K, Donnemiller E, Goebel G, Brenneis C, Virgolini I, Wenning GK, Poewe W: Voxel-wise analysis of [123I] beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease. Brain. 2005"},{"key":"27_CR82","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s007020070077","volume":"107","author":"W Staffen","year":"2000","unstructured":"Staffen W, Mair A, Unterrainer J, Trinka E, Ladurner G: Measuring the progression of idiopathic Parkinson's disease with [123I] beta-CIT SPECT. J Neural Transm. 2000, 107: 543-552. 10.1007\/s007020070077.","journal-title":"J Neural Transm"},{"key":"27_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroimage.2004.04.039","volume":"23","author":"S Thobois","year":"2004","unstructured":"Thobois S, Jahanshahi M, Pinto S, Frackowiak R, Limousin-Dowsey P: PET and SPECT functional imaging studies in Parkinsonian syndromes: from the lesion to its consequences. Neuroimage. 2004, 23: 1-16. 10.1016\/j.neuroimage.2004.04.039.","journal-title":"Neuroimage"},{"key":"27_CR84","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1212\/WNL.55.10.1540","volume":"55","author":"Parkinson Study Group","year":"2000","unstructured":"Parkinson Study Group: A multicenter assessment of dopamine transporter imaging with DOPASCAN\/SPECT in parkinsonism. Neurology. 2000, 55: 1540-1547.","journal-title":"Neurology"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-7-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-7-27\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-7-27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-7-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T08:37:30Z","timestamp":1630485450000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-7-27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,1]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["27"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-7-27","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,1]]},"assertion":[{"value":"27 September 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"27"}}